Human Genome Epidemiology Literature Finder
|
Records 1 - 24 (of 24 Records) |
| Query Trace: Liver Neoplasms and TP53[original query] |
|---|
| Impact of TP53 codon 72 and MDM2 promoter 309 allelic dosage in a Moroccan population with hepatocellular carcinoma. The International journal of biological markers 0 26 (4): 229-33. Ezzikouri Sayeh, Essaid El Feydi Abdellah, Afifi Rajae, Benazzouz Mustapha, Hassar Mohammed, Pineau Pascal, Benjelloun Souma |
| Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis. PloS one 2012 7 (6): e37707. Villar Stephanie, Ortiz-Cuaran Sandra, Abedi-Ardekani Behnoush, Gouas Doriane, Nogueira da Costa Andre, Plymoth Amelie, Khuhaprema Thiravud, Kalalak Anant, Sangrajrang Suleeporn, Friesen Marlin D, Groopman John D, Hainaut Pier |
| Somatic changes in primary liver cancer in Russia: a pilot study. Mutation research 2013 Aug 755 (2): 90-9. Kalinina Olga, Marchio Agnès, Urbanskii Aleksandr I, Tarkova Aleksandra B, Rebbani Khadija, Granov Dmitri A, Dejean Anne, Generalov Mikhail I, Pineau Pasc |
| Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma. Epidemiology (Cambridge, Mass.) 2013 Sep 24 (5): 671-81. Long Xi-Dai, Zhao Dong, Wang Chao, Huang Xiao-Ying, Yao Jin-Guang, Ma Yun, Wei Zhong-Hua, Liu Min, Zeng Li-Xiao, Mo Xiao-Qiang, Zhang Jian-Jun, Xue Feng, Zhai Bo, Xia Qia |
| Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics 2013 Aug 102 (2): 74-83. Tornesello Maria Lina, Buonaguro Luigi, Tatangelo Fabiana, Botti Gerardo, Izzo Francesco, Buonaguro Franco |
| Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma. Gastroenterology 2017 Mar . Zhang Weilong, He Huan, Zang Mengya, Wu Qifeng, Zhao Hong, Lu Ling-Ling, Ma Peiqing, Zheng Hongwei, Wang Nengjin, Zhang Ying, He Siyuan, Chen Xiaoyan, Wu Zhiyuan, Wang Xiaoyue, Cai Jianqiang, Liu Zhihua, Sun Zongtang, Zeng Yi-Xin, Qu Chunfeng, Jiao Yuch |
| RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival. Future oncology (London, England) 2018 6 14 (25): 2615-2625. Fang Aiping, Zhou Shijie, Su Xiaolan, Liu Chuang, Chen Xiaoxin, Wan Yang, Lei Xiaohong, Xie Linshen, Jia Yiping, Wang Wenzhi, Yang Luo, Song Xuejiao, Yao Yuq |
| Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma. Frontiers in genetics 2018 2 9 2. Kancherla Venkatesh, Abdullazade Samir, Matter Matthias S, Lanzafame Manuela, Quagliata Luca, Roma Guglielmo, Hoshida Yujin, Terracciano Luigi M, Ng Charlotte K Y, Piscuoglio Salvato |
| A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology 2018 Jan . Li X C, Wang M Y, Yang M, Dai H J, Zhang B F, Wang W, Chu X L, Wang X, Zheng H, Niu R F, Zhang W, Chen K |
| Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma. European journal of cancer (Oxford, England : 1990) 2019 6 116 56-66. Howell Jessica, Atkinson Stephen R, Pinato David J, Knapp Susanne, Ward Caroline, Minisini Rosalba, Burlone Michela E, Leutner Monica, Pirisi Mario, Büttner Reinhard, Khan Shahid A, Thursz Mark, Odenthal Margarete, Sharma Rohi |
| Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma. Hepatology (Baltimore, Md.) 2019 6 71 (1): 164-182. Nault Jean-Charles, Martin Yoann, Caruso Stefano, Hirsch Théo Z, Bayard Quentin, Calderaro Julien, Charpy Cecile, Copie-Bergman Christiane, Ziol Marianne, Bioulac-Sage Paulette, Couchy Gabrielle, Blanc Jean-Frédéric, Nahon Pierre, Amaddeo Giuliana, Ganne-Carrie Nathalie, Morcrette Guillaume, Chiche Laurence, Duvoux Christophe, Faivre Sandrine, Laurent Alexis, Imbeaud Sandrine, Rebouissou Sandra, Llovet Josep M, Seror Olivier, Letouzé Eric, Zucman-Rossi Jessi |
| Hepatitis B virus preS2?38-55 variants: A newly identified risk factor for hepatocellular carcinoma. JHEP reports : innovation in hepatology 2020 9 2 (5): 100144. Cohen Damien, Ghosh Sumantra, Shimakawa Yusuke, Ramou Njie, Garcia Pierre Simon, Dubois Anaëlle, Guillot Clément, Kakwata-Nkor Deluce Nora, Tilloy Valentin, Durand Geoffroy, Voegele Catherine, Ndow Gibril, d'Alessandro Umberto, Brochier-Armanet Céline, Alain Sophie, Le Calvez-Kelm Florence, Hall Janet, Zoulim Fabien, Mendy Maimuna, Thursz Mark, Lemoine Maud, Chemin Isabel |
| STK11 p.F354L Germline Mutation in a Case of Multiple Gastrointestinal Tumors. Case reports in gastroenterology 2020 11 14 (3): 547-553. Kojima Yohei, Ohtsuka Kouki, Ishii Shun, Aso Nobuyoshi, Ohki Atsuko, Hashimoto Yoshikazu, Takeuchi Hirohisa, Ohnishi Hiroaki, Abe Nobutsu |
| The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma. Journal of gastrointestinal oncology 2021 7 12 (3): 1132-1140. Xu Hao, Liang Xiao-Lu, Liu Xiao-Guang, Chen Nian-Pi |
| Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis. Molecular genetics & genomic medicine 2021 Jun e1697. Shen Dong, Zhang Junling, Yuan Kai, Zhao Jing, Zhao Zhengyi, Cui Longgang, Zhang Yuzi, Wang Guoqiang, Cai Shangli, Bai Yuezong, Li Wei, Huang Xia |
| TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy. Pharmacogenomics and personalized medicine 2021 2 14 269-278. Song Kangjian, He Fu, Xin Yang, Guan Ge, Huo Junyu, Zhu Qingwei, Fan Ning, Guo Yuan, Zang Yunjin, Wu Liq |
| Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas. Journal of hepato-biliary-pancreatic sciences 2022 8 . Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Nagashima Takeshi, Yamaguchi K |
| Four-copy number alteration (CNA)-related lncRNA prognostic signature for liver cancer. Scientific reports 2022 Aug 12 (1): 14261. Cheng Zhenyun, Guo Yan, Sun Jingjing, Zheng L |
| Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes. Frontiers in oncology 2022 12 863266. Ye Tingbo, Lin Leilei, Cao Lulu, Huang Weiguo, Wei Shengzhe, Shan Yunfeng, Zhang Zhongji |
| Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma. Frontiers in cell and developmental biology 2022 5 10 844013. Zhang Guixiong, Fan Wenzhe, Wang Hongyu, Wen Jie, Tan Jizhou, Xue Miao, Li Jiapi |
| Mutations in TP53 and PIK3CA genes in hepatocellular carcinoma patients are associated with chronic Schistosomiasis. Saudi journal of biological sciences 2022 2 29 (2): 848-853. AlGabbani Qwa |
| Comprehensive analyses of the clinicopathological features and genomic mutations of combined hepatocellular-cholangiocarcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 2023 9 . Takashi Ito, Takamichi Ishii, Haruhiko Takeda, Shinji Sumiyoshi, Katsuhiro Tomofuji, Satoshi Wakama, Kenta Makino, Hiroshi Horie, Ken Kumagai, Atsushi Takai, Elena Yukie Uebayashi, Satoshi Ogiso, Ken Fukumitsu, Hironori Haga, Hiroshi Seno, Etsuro Hata |
| Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma. Cancer genetics 2023 7 276-277 30-35. Mei Ling Chong, James Knight, Gang Peng, Weizhen Ji, Hongyan Chai, Yufei Lu, Shengming Wu, Peining Li, Qiping |
| A lipid metabolism-based prognostic risk model for HBV-related hepatocellular carcinoma. Lipids in health and disease 2023 4 22 (1): 46. Zhou Lili, Xia Shaohuai, Liu Yaoyao, Ji Qiang, Li Lifeng, Gao Xuan, Guo Xiaodi, Yi Xin, Chen Fe |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: